DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.10
-0.37 (-4.37%)
Jan 30, 2026, 2:08 PM EST - Market open
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $433.99 million as of January 30, 2026. Its market cap has increased by 102.14% in one year.
Market Cap
433.99M
Enterprise Value
376.25M
1-Year Change
102.14%
Ranking
Category
Stock Price
$8.10
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $433.99M, an increase of 1,082.52%. That is a compound annual growth rate of 41.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 441.10M | 6.42% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 476.25M |
| Bicycle Therapeutics | 456.44M |
| Vanda Pharmaceuticals | 454.45M |
| Immutep | 453.26M |
| Monopar Therapeutics | 450.64M |
| PureTech Health | 449.40M |
| NovaBridge Biosciences | 446.18M |
| Absci | 442.09M |